ARDD moved from Copenhagen to Boston out of necessity, but that was the universe doing its thing: this yearβs event was a standout.
Link as first comment.

ARDD moved from Copenhagen to Boston out of necessity, but that was the universe doing its thing: this yearβs event was a standout.
Link as first comment.
Pharma has the podium as Novo and Lilly stop talking about GLP-1 longevity and start measuring it, bringing early aging data to ARDD.
Link as first comment.
Aging is pleased to announce that we are a media partner of the 13th Aging Research & Drug Discovery Meeting (ARDD), taking place October 1β3 at Harvard University in Boston, MA.
π Learn more:
https://bit.ly/3UfNcue
David Sinclair has developed a version of epigenetic reprogramming that uses a cocktail of small molecules instead of a gene therapy encoding transcription factors. The work was presented for the first time to a packed room at #ARDD yesterday. My story in @endpts.com: endpoints.news/david-sincla...
Aging is pleased to announce that we are a media partner of the 13th Aging Research & Drug Discovery Meeting (ARDD), taking place October 1β3 at Harvard University in Boston, MA.
π Learn more:
https://bit.ly/3UfNcue
Aging is pleased to announce that we are a media partner of the 13th Aging Research & Drug Discovery Meeting (ARDD), taking place October 1β3 at Harvard University in Boston, MA.
π Learn more:
https://bit.ly/3UfNcue
Aging is pleased to announce that we are a media partner of the 13th Aging Research & Drug Discovery Meeting (ARDD), taking place October 1β3 at Harvard University in Boston, MA.
π Learn more:
https://bit.ly/3UfNcue
Aging is pleased to announce that we are a media partner of the 13th Aging Research & Drug Discovery Meeting (ARDD), taking place October 1β3 at Harvard University in Boston, MA.
π Learn more:
https://bit.ly/3UfNcue